KLRB1 and tuberculosis: Thus, the current study identifies and defines Mtb-inhibiting function and mechanisms of a fast-acting primary CD4+CD161+T-cell subset in unexposed healthy humans as well as dysfunction of this CD4+CD161+T-cell immunity mechanism in TB patients.